We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
GUFICBIO.NSE

Price
329.60
Stock movement up
+19.80 (6.39%)
Company name
Gufic Biosciences Limited
Exchange
(NSE
,
Currency
INR
)
Sector
Healthcare >
Drug Manufacturers - Specialty & Generic
Market cap
33.05B
Ent value
38.30B
Price/Sales
4.08
Price/Book
5.76
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
38.92
Forward P/E
-
PEG
-
EPS growth
24.96%
1 year return
6.58%
3 year return
10.12%
5 year return
44.84%
10 year return
36.02%
Last updated: 2025-04-12

DIVIDENDS

GUFICBIO.NSE does not pay dividends or no data was received

VALUATION

Valuation Ratios

Valuation Ratios data
Trailing P/E38.92
Price to OCF399.01
Price to FCF399.01
Price to EBITDA90.66
EV to EBITDA105.06

Valuation (Sales/Book Value)

Valuation (Sales/Book Value) data
Price to Sales4.08
Price to Book5.76
EV to Sales4.73

FINANCIALS

Per share

Per share data
Current share count100.28M
EPS (TTM)8.47
FCF per share (TTM)0.83

Income statement

Income statement data
Revenue (TTM)8.11B
Gross profit (TTM)3.26B
Operating income (TTM)961.00M
Net income (TTM)849.28M
EPS (TTM)8.47
EPS (1y forward)-

Margins

Margins data
Gross margin (TTM)40.24%
Operating margin (TTM)11.86%
Profit margin (TTM)10.48%

Balance Sheet

Please create a free account or log in to access this chart
Balance Sheet data
Cash57.37M
Net receivables0.00
Total current assets5.78B
Goodwill0.00
Intangible assets0.00
Property, plant and equipment0.00
Total assets11.05B
Accounts payable1.69B
Short/Current long term debt2.96B
Total current liabilities3.54B
Total liabilities5.30B
Shareholder's equity5.74B
Net tangible assets0.00

Cash flow

Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)82.83M
Capital expenditures (TTM)0.00
Free cash flow (TTM)82.83M
Dividends paid (TTM)0.00

Financial returns

Please create a free account or log in to access this chart
Financial returns data
Return on Equity14.79%
Return on Assets7.69%
Return on Invested Capital11.84%
Cash Return on Invested Capital1.15%

STOCK INFORMATION

Stock chart

Stock price data
Open314.50
Daily high330.70
Daily low314.50
Daily Volume40K
All-time high485.45
1y analyst estimate-
Beta0.80
EPS (TTM)8.47
Dividend per share-
Ex-div date17 Sep 2024
Next earnings date-

Downside potential

Downside potential data
GUFICBIO.NSES&P500
Current price drop from All-time high-32.10%-12.89%
Highest price drop-93.60%-56.47%
Date of highest drop12 Mar 20099 Mar 2009
Avg drop from high-50.17%-11.07%
Avg time to new high61 days12 days
Max time to new high2697 days1805 days
COMPANY DETAILS
GUFICBIO.NSE (Gufic Biosciences Limited) company logo
Marketcap
33.05B
Marketcap category
Large-cap
Description
Gufic Biosciences Limited manufactures and markets active pharmaceutical ingredients (APIs), generic pharmaceuticals, and related services in India, Africa, Asia, Europe, Australia, North America, South America, and internationally. It manufactures APIs and bulk drugs, such as antifungals, anesthetics, immuno suppressants, and intermediates for antifungals. The company also manufactures lyophilized injections, which include antibiotic, antifungal, cardiac medications, infertility treatments, antiviral solutions, and proton pump inhibitors (PPIs) segments. In addition, the company offers criti care, criticare life, ferticare, and spark pharmaceutical products; and herbal, aesthaderm, gufic stridden, and personal care products. It supplies its products to hospital chains and medical facilities. The company was founded in 1970 and is based in Mumbai, India.
Employees
1491
Website
https://www.gufic.com
Investor relations
-
SEC filings
GUFICBIO.NSE SEC filings
CEO
Country
India
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
UNDERSTAND THE BUSINESS
COMPANY NEWS
All newsPress releases
No items found
Disclaimer
Skyfall Technology OÜ assumes no responsibility or liability for any errors or omissions in the content of this site. The information contained in this site is provided on an “as is” basis with no guarantees of completeness, accuracy, usefulness or timeliness. Please also note, that any action you take upon the information provided on this website is strictly at your own risk. This website is intended to be used and must be used for informational purposes only and you should take independent financial advice from a professional and independently research and verify everything you see on the site.
Menu
HomePortfolio ManagementCompany ScreenerGreen InvestmentExchangesContact Us
Language
ENHUNOSVDAFIESDENLFRITPTPLCSSKROELTRRUAF
© 2024 Skyfall Technology OÜ All Rights Reserved